menu
    • menu

    Company profile for Dr. Falk Pharma

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Dr. Falk Pharma, a renowned authority in digestive and metabolic medicine, excels as a research-driven family enterprise with a worldwide footprint. Our dedication lies in pioneering the development and dissemination of cutting-edge pharmaceuticals, aimed at enhancing the health and quality of life for patients across the globe.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Dr. Falk PharmaGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Leinenweberstr. 5 79108 Freiburg
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://drfalkpharma.com/en/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/dr.-falk-pharma
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck Signs Agreement with Dr. Falk Pharma GmbH for MK-8690
    Merck Signs Agreement with Dr. Falk Pharma GmbH for MK-8690

    04 Nov 2025

    // PRESS RELEASE

    https://www.merck.com/news/merck-signs-agreement-with-dr-falk-pharma-gmbh-for-certain-development-and-commercialization-rights-to-mk-8690-pra-052-an-investigational-anti-cd30-ligand-monoclonal-antibody/

    PRESS RELEASE
    04 Nov 2025
    Share Share
    Dr. Falk Pharma, Allianthera Partner for AhR Agonist Development
    Dr. Falk Pharma, Allianthera Partner for AhR Agonist Development

    30 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/30/3123816/0/en/Dr-Falk-Pharma-and-Allianthera-Suzhou-Biopharmaceuticals-Forge-Strategic-Partnership-for-Novel-AhR-Agonist-Development.html

    GLOBENEWSWIRE
    30 Jul 2025
    Share Share
    Renexxion, Dr. Falk Complete Ph2b Gastroparesis Trial
    Renexxion, Dr. Falk Complete Ph2b Gastroparesis Trial

    27 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/27/3088578/0/en/Renexxion-Ireland-Ltd-and-Dr-Falk-Pharma-GmbH-Announce-Completion-of-Enrollment-of-the-Global-Phase-2b-Study-Evaluating-Naronapride-in-Gastroparesis-MOVE-IT.html

    GLOBENEWSWIRE
    27 May 2025
    Share Share
    Dr. Falk Pharma reports positive phase 3 trial on norucholic acid
    Dr. Falk Pharma reports positive phase 3 trial on norucholic acid

    07 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/07/3075765/0/en/Dr-Falk-Pharma-announces-positive-results-from-its-pivotal-phase-3-trial-on-norucholic-acid-in-primary-sclerosing-cholangitis.html

    GLOBENEWSWIRE
    07 May 2025
    Share Share
    Dr. Falk Pharma Acquires Kynos, Focuses on Acute Pancreatitis
    Dr. Falk Pharma Acquires Kynos, Focuses on Acute Pancreatitis

    29 Oct 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=936541&lang=en

    ACCESSWIRE
    29 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search